# A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.

> **NCT04355845** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Sumatriptan
- **DRUG:** PF-06651600

## Key facts

- **NCT ID:** NCT04355845
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2020-08-10
- **Final completion:** 2020-08-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355845, "A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04355845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*